Polyglandular autoimmune diseases in a dermatological clinical setting: Vitiligo-associated autoimmune diseases

European Journal of Dermatology

Volumn 20, Issue 3, 2010, Pages 354-358

  Amerio, Paolo ^a   Di Rollo, Daniela ^a,b   Carbone, Angelo ^a   Auriemma, Matteo ^a   Marra, Maria Elena ^a   De Remigis, Pierluigi ^c   Feliciani, Claudio ^b   Tracanna, Marco ^a   Tulli, Antonio ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c SS Annunziata Hospital   (Italy)

Author keywords

APS; Autoantibodies; Autoimmune diseases; Autoimmune polyglandular syndromes; Thyroid autoimmune disease; Vitiligo

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; ALOPECIA AREATA; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GASTRITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; QUESTIONNAIRE; SEX DIFFERENCE; VITILIGO;

ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNITY; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; POLYENDOCRINOPATHIES, AUTOIMMUNE; PREVALENCE; RETROSPECTIVE STUDIES; VITILIGO; YOUNG ADULT;

EID: 77952824439     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2009.0939     Document Type: Article

References (29)

1. Sehgal VN, Srivastava G. Vitiligo: Auto-immunity and immune responses. Int J Dermatol 2006; 45: 583-589
2. Kemp EH, Gavalas NG, Gawkrodger DJ, Weetman AP. Auto-antibody responses to melanocytes in the depigmenting skin disease vitiligo. Autoimmunity Rev 2007; 6: 138-142
3. Hedstrand H, Ekwall O, Olsson MJ, Landgren E, Kemp EH, Weetman AP, et al. The transcription factors SOX9 and SOX10 are melanocyte autoantigens related to vitiligo in autoimmune polyendocrine syndrome type 1. J Biol Chem 2001; 276: 35390-35395 (Pubitemid 37384333)
4. Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 2003; 16: 90-100.
5. Spritz RA. The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res 2007; 20: 271-278 (Pubitemid 47057312)
6. Liu JB, Li M, Chen H, Zhong SQ, Yang S, Du WD, Hao JH, Zhang TS, Zhang XJ, and Zeegers MP. Association of vitiligo with HLA-A2: a meta-analysis. J Eur Acad Dermatol Venereol 2007; 21: 205-213.
7. Neufeld M, Blizzard RM. Polyglandular autoimmune diseases. In: Symposium on Autoimmune Aspects of endrocrine Disorders (Pinchera A, Doniach D, Fenzi GF, Baschieri L, eds). New York: Academic Press 1980: 357-365
8. Betterle C, Zanchetta R. Update on autoimmune syndromes (APS). Acta Bio Med 2003; 74: 9-33.
9. Betterle C, Lazzarotto F, Precotto F. Autoimmune polyglandular syndrome Type 2: the tip of an iceberg? Clin Exp Immunol 2004; 137: 225-233
10. Alkhateeb A, Fain PR, Thody A, et al. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003; 16: 204-214 (Pubitemid 36597056)
11. Akrem J, Baroudi A, Aichi T, Houch F, Hamdaoui MH. Profile of vitiligo in the south of Tunisia. International Journal of Dermatology 2008; 47: 670-674
12. Gauthier Y, Cairo Andre M, Taieb A. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 2003; 16: 322-332
13. Nordlund JJ, Ortonne JP, Le Poole IC. Vitiligo Voulgaris. In the Pigmantary System: Physiology and Pathophysiology 2006; 551-598
14. Hegedus L, Heidenheim M, Gervil M, Hjalgrim H, Hoier-Madsen M. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol 1994; 74: 120-123 (Pubitemid 24102472)
15. Brand O, Gough S, Heward J. HLA CTLA-4, and PTPN22: the shared genetic master-key to autoimmunity? Expert Rev Mol Med 2005; 7: 1-15.
16. Birlea SA, Fain PR, Spritz RA. A Romanian population isolate with high frequency of vitiligo and associated autoimmune diseases. Arch Dermatol 2008; 144: 310-316
17. Zhang Z, Xu SX, Zhang FY, et al. The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients. Arch Dermatol Res 2009; 301: 167-173
18. Grimes PE. New insights and new therapies in vitiligo. JAMA 2005; 293: 730-735
19. Amerio P, Tracanna M, De Remigis P, et al. Vitiligo associated with other autoimmune disease: polyglandular autoimmune syndrome types 3 B+C And 4. Clin Exp Dermatol 2006; 31: 746-749 (Pubitemid 44086827)
20. Daneshpazhooh M, Mostofizadeh MG, Behjati J, Akhyani M and Robati RM. Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatology 2006 10; 6: 3.
21. Abenavoli L, Proietti I, Leggio, Ferrulli A, Vonghia L, Capizzi R, Rotoli M, Amerio PL, Gasbarrini G, Addolorato A. Cutaneous manifestations in celiac disease. World J Gastroenterol 2006; 12: 843-852
22. Zauli D, Tosti A, Biasco G, et al. Prevalence of autoimmune atrophic gastritis in vitiligo. Digestion 1986; 34: 169-172 (Pubitemid 16064242)
23. Tazi-Ahnini R, McDonagh AJ, Wengraf DA, Lovewell TR, Vasilopoulos Y, Messenger AG, Cork MJ and Gawkrodger DJ. The autoimmune regulator gene (AIRE) is strongly associated with vitiligo. British Journal of Dermatology 2008; 159(3): 591-596.
24. Tazi-Ahnini R, Cork MJ, Gawkrodger DJ. Role of the autoimmune regulator (AIRE) gene in alopecia areata: strong association of a potentially functional AIRE polymorphism with alopecia universalis. Tissue Antigens 2002; 60: 489-495 (Pubitemid 36177271)
25. Farrokhi S, Hojjat Farsanji M, Noohpishah MK, Tahmasei R. Assesment of the immune system in 55 Iranian patients with vitiligo. J Eur Acad Dermatol Venereol 2005; 19: 706-711 (Pubitemid 41743323)
26. Zettining G, Tanew A, Fischer G, Mayr W, Dudczak R, Weissel M. Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume? Clin Exp Immunol 2003; 131: 347-354
27. Korkij W, Saltani K, Simij S, Marcincin PG, Chuang TY. Tissue specific autoantibodies and autoimmune disorders in vitiligo and alopecia areata: a retrospective study. J Cutan Pathol 1984; 11: 722-730 (Pubitemid 15175263)
28. Mosca M, Carli L, D'Ascanio A, et al. Occurrence of organspecific and systemic autoimmune disease among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews. Clin Rheumatol 2008; 27: 1045-1048
29. Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes: immunogenetics and long term follow up. J Clin Endocrinol Metabol 2003; 88: 2983-2992